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SUMMARY
Introduction. Evaluation ofLeishmania drug susceptibility depends on in vitro SbV susceptibility assays, which are labour-
intensive and may give a biased view of the true parasite resistance. Molecular markers are urgently needed to improve and
simplify the monitoring of SbV-resistance. We analysed here the gene expression proﬁle of 21 L. braziliensis clinical isolates
in vitro deﬁned as SbV-resistant and -sensitive, in order to identify potential resistance markers.Methods. The diﬀerential
expression of 13 genes involved in SbV metabolism, oxidative stress or housekeeping functions was analysed during in vitro
promastigote growth. Results. Expression proﬁles were up-regulated for 5 genes only, each time aﬀecting a diﬀerent set of
isolates (mosaic picture of gene expression). Two genes, ODC (ornithine decarboxylase) and TRYR (trypanothione
reductase), showed a signiﬁcantly higher expression rate in the group of SbV-resistant compared to the group of SbV-
sensitive parasites (P<0·01). However, analysis of individual isolates showed bothmarkers to explain only partially the drug
resistance.Discussion. Our results might be explained by (i) the occurrence of a pleiotropic molecular mechanism leading
to the in vitro SbV resistance and/or (ii) the existence of diﬀerent epi-phenotypes not revealed by the in vitro
SbV susceptibility assays, but interfering with the gene expression patterns.
Key words: Leishmania (Viannia) braziliensis, antimony resistance, gene expression proﬁling, promastigotes, clinical
isolates.
INTRODUCTION
Protozoan parasites of the genus Leishmania cause a
broad spectrum of diseases, collectively known as
leishmaniasis, that occur predominantly in tropical
and subtropical regions. It is estimated that world-
wide there is an annual incidence of 1·5–2 million
new cases, with up to 350 million people at risk of
infection (Murray et al. 2005). Chemotherapy is the
main control strategy for leishmaniasis and penta-
valent antimonials (SbV) remain the mainstay, but
their eﬃcacy is threatened by the emergence of drug-
resistant Leishmania parasites, as described in several
endemic regions (Lira et al. 1999; Hadighi et al. 2006;
Rojas et al. 2006; Yardley et al. 2006).
The in vitro intracellular amastigote-macrophage
model is currently considered the gold standard for
susceptibility testing of Leishmania clinical isolates
(Vermeersch et al. 2009). But the screening entails a
complex, labour-intensive and time-consuming pro-
tocol, which involves in vitro infection of primary
macrophages with an infective stage of Leishmania
parasites (metacyclic promastigotes, axenic amasti-
gotes, or ex vivo amastigotes), 3–7 days SbV exposure
and the ﬁnal step of microscopical evaluation of
the diﬀerent infections (Neal and Croft, 1984;
Vermeersch et al. 2009). In view of this scenario,
research is needed to identify molecular markers that
would by-pass these limitations and would improve
the epidemiological surveillance of SbV-resistance
in the ﬁeld. These markers are not yet available, due
to the limited knowledge of the molecular and
biochemical mechanisms underlying resistance to
SbV, especially in clinical isolates.
Even if intracellular amastigotesmay be considered
as the clinically relevant stage, the current proto-
cols to study their gene expression require ex-
treme care to ensure reproducibility of the results
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(Decuypere et al. 2008) and are not adapted to the
study of a large number of isolates. In contrast,
promastigotes can be easily cultivated and harvested
with minimal risk of aﬀecting their biological state
under well-controlled in vitro conditions (Decuypere
et al. 2008). Furthermore, molecular changes during
promastigote diﬀerentiation serve as pre-adaptations
for parasite transmission and initial infection stages
in the vertebrate host (Sacks, 1989; Saxena et al.
2003). Hence, a time-course analysis of gene ex-
pression changes throughout the promastigote
growth cycle may show diﬀerences in molecular
adaptations of parasites to intracellular life. Our
previous study on L. donovani clinical isolates indi-
cated that promastigote expression-curves could
indeed reveal molecular features distinguishing iso-
lates with diﬀerent in vitro SbV susceptibility pheno-
types (Decuypere et al. 2008).Moreover, considering
that the in vitro growth rates could vary among
diﬀerent isolates, expression-curves are advisable to
guarantee a reliablemolecular comparison of identical
developmental stages among various isolates under
study.
In the present work, we aimed to compare the
gene expression patterns of 21 L. braziliensis clinical
isolates showing 2 diﬀerent phenotypes of in vitro
SbV susceptibility (respectively sensitive and resist-
ant). Promastigotes were used, as this life-stage can
be easily cultured for high-throughput applications.
We used real-time quantitative PCR (qPCR) to assess
the RNA expression proﬁles of 13 genes encoding
proteins with roles in SbV metabolism, oxidative
stress or housekeeping functions and compared mol-
ecular data to the 2 in vitro deﬁned SbV phenotypes.
MATERIALS AND METHODS
Parasites and in vitro culture
In total, 21 L. braziliensis isolates were obtained
from conﬁrmed cutaneous or mucosal leishmaniasis
patients recruited at the Institute of Tropical Medi-
cine Alexander von Humboldt in Lima, Peru, within
the framework of LeishNatDrug-R, a multicentre
study on SbV treatment failure in leishmaniasis.
Isolates were essentially obtained before treatment
of patients, typed by PCR-RFLP analysis of hsp70
and cpb genes (Garcia et al. 2005) and tested as
intracellular amastigotes for their in vitro suscepti-
bility to SbV (Yardley et al. 2006) (see Table 1 for
Table 1. Geographical origin, in vitro SbV and SbIII susceptibility data of Peruvian Leishmania braziliensis
isolates included in the study and corresponding clinical data: disease (CL, cutaneous leishmaniasis,
ML, mucosal leishmaniasis) and treatment outcome (TF, treatment failure; C, cure)
International Code
L. braziliensis
Geographical origin
(state, province)
A.I.
SbV¥
A.I.
SbIII¥ Disease
Treatment
ouctome
SbV-sensitive isolates
MHOM/PE/01/PER005/0 Loreto, Ucayali 1 ND CL TF
MHOM/PE/03/PER130/0 Cusco, Echarate 1 0 CL TF
MHOM/PE/03/PER163/0 Huánuco, Leoncio Prado 2 0 CL C
MHOM/PE/03/PER186/0 Junín, Satipo 2 1 CL C
SbV-resistant isolates
MHOM/PE/01/PER002/0 Madre de Dios, Tambopata 6 2 CL TF
MHOM/PE/01/PER006/1 Junín, Satipo 6+ ND CL TF
MHOM/PE/01/PER012/1 Cusco, Calca 6+ ND CL TF
MHOM/PE/01/PER014/0 Junín, Satipo 6+ ND CL TF
MHOM/PE/02/PER015/0 Ucayali, Coronel Portillo 6+ 2 CL TF
MHOM/PE/02/PER016/0 Huánuco, Puerto Inca 6+ ND CL C
MHOM/PE/02/PER067/0 Cusco, La Convención 6+ ND CL TF
MHOM/PE/02/PER086/0 Pasco, Oxapampa 6+ 0 CL TF
MHOM/PE/02/PER094/0 Huánuco, Puerto Inca 6 2 CL C
MHOM/PE/02/PER104/0 Madre de Dios, Tambopata 6+ 6+ CL TF
MHOM/PE/02/PER122/0 Madre de Dios, Tambopata 6+ ND CL C
MHOM/PE/03/PER157/0 Madre de Dios, Tambopata 6+ 2 CL C
MHOM/PE/03/PER182/0 Ayacucho, La Mar 6 5 CL C
MHOM/PE/03/PER201/0 Loreto, Requena 6 1 ML C
MHOM/PE/03/PER215/0 Ucayali, Coronel Portillo 6 2 ML C
MHOM/PE/03/PER231/0 Junín, Satipo 5 2 ML C
MHOM/PE/03/PER260/0 Madre de Dios, Tahuamanu 6 2 ML C
¥ The in vitro SbV or SbIII susceptibility of a tested isolate was expressed as an ‘activity index’ (A.I.), i.e. as the ratio of the
ED50 (50% eﬀective dose) of that tested isolate to the ED50 of the WHO reference L. braziliensis strain MHOM/BR/75/
M2903. Isolates with an A.I. of 0–2 were considered sensitive to SbV or SbIII (0, more sensitive than the reference strain
M2903), while isolates with an A.I. of 3 or higher were considered resistant. Data shown were reported by Yardley
et al. 2006.
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summary of isolate features). Promastigote forms
were grown at 24 °C in a biphasic medium consisting
of rabbit blood agar overlaid with medium 199
(M199; Sigma) containing 20% heat-inactivated
fetal bovine serum (FBS; Lonza Bioscience), 25 mM
Hepes (pH 7·4), 100 units/ml penicillin and
100 μg/ml streptomycin (Lonza). Growth curves
were initiated by inoculating 3×106 parasites/ml in
5ml of M199-20% FBS. Two independently grown
cultures and corresponding harvests at 24 h (early-
log phase), 72 h (late-log phase), 120 h (early-
stationary phase) and 168 h (late-stationary phase)
time-points were performed in parallel for each
isolate (biological replicates). RNA sampling proto-
cols used here were described previously (Decuypere
et al. 2005). All studied isolates showed similar
growth behaviour during in vitro culture, thereby
allowing synchronization of the promastigote growth
cycle among isolates. The in vitro passage numbers
(post-isolation from patients) were: (i) in the group
of SbV-sensitive isolates: mean±standard deviation
(S.D.): 20·5±5·9; (ii) in the group of SbV-resistant
isolates: mean±S.D.: 19·9±4·5. There was no stat-
istically signiﬁcant diﬀerence in the mean passage
number between isolate groups (P=0·9, t-test).
Previous work of our group showed that the in vitro
SbV-resistant phenotype was stable far beyond these
passage numbers (Laurent et al. 2007, and unpub-
lished results).
RNA isolation and real-time quantitative PCR
Total RNA was isolated, analysed and reverse tran-
scribed as described before (Decuypere et al. 2005).
The resulting cDNA was diluted 10-fold, and 2 μl
was used as template in 25 μl of SYBR Green-based
quantitative PCR (qPCR) reactions on the iCycler
(Bio-Rad), as previously described (Decuypere
et al. 2005), with only the modiﬁcation that ampli-
ﬁcation was done for 34 cycles.We analysed 13 genes.
First, a set of 8 genes putatively involved in
SbV metabolism and/or implicated in laboratory-
induced resistance (Ashutosh et al. 2007). This set
includes genes with predicted function in transport
(LbAQP1, MRPA), thiol biosynthesis/redox meta-
bolism (GSH1, GSH2, ODC, TRYR) and cellular
reduction (ACR2, TDR1). Secondly, 2 genes result-
ing from a diﬀerential screen of L. braziliensis
SbV-resistant and -sensitive isolates and putatively
involved in RNA poly(A)-tail metabolism (PABP,
PAP14) (Decuypere, 2007). Thirdly, 2 genes coding
for housekeeping functions:Actin (cytoskeleton func-
tion) and S8 (ribosomal function). Fourthly, the
META1 gene, up-regulated in the infective meta-
cyclic stage of distinct Leishmania species (Uliana
et al. 1999; Gamboa et al. 2007), was analysed using
primers and conditions reported elsewhere (Gamboa
et al. 2007).
Full-length gene sequences in L. major and
L. infantum genome databases were used as queries
for BLAST searches in the L. braziliensis genome
database (GeneDB, http://www.genedb.org/). Pri-
mers (Table 2) were designed with Primer3 (Rozen
and Skaletsky, 2000) and tested for speciﬁcity using
NCBI BLAST (http://www.ncbi.nlm.nih.gov/
BLAST).
Data analysis and statistics
Analysis was performed on duplicate biological
samples that were each assayed in triplicate. The
arithmetic average threshold cycle (Ct) was used for
data analysis. For each primer set, reaction eﬃciency
estimates were derived from standard curves gen-
erated by serial dilutions of a cDNA pool of a
promastigote sample. Eﬃciencies ranged between
1·84 and 2·07 and correlation coeﬃcients were
50·997 (iCycler 3.1 software, Bio-Rad).
The Ct values of each qPCR run were imported as
Excel ﬁles into qBasePlus (Biogazelle NV, Zulte,
Belgium), a software for real-time PCR data analysis
based on the geNorm method (Vandesompele et al.
2002) and qBase technology (Hellemans et al. 2007).
Four genes (ACR2, GSH2, PAP14 and TDR1)
showed the most stable expression in our sample
panel (geNorm stability mean M-value and mean
coeﬃcient of variation lower than 0·35 and 15%,
respectively) and data were normalized to their geo-
metric mean. The analysis of 13 genes in 168 samples
(21 parasite isolates×4 time-points in duplicate
harvests) could be performed as one integrated ex-
periment by performing inter-plate calibrations
(based on 3 cDNA samples included in each qPCR
run for that purpose). Overall, 1084 out of 1092
data points did not diﬀer by more than 20% in CV
(coeﬃcient of variation) of normalized relative
quantities between biological replicates, demon-
strating the reproducibility of our methodology
(Table 2).
The fold change of gene expression between
log- and stationary-phase promastigotes (time-points
24 h and 72 h vs 120 h and 168 h of the growth curves,
respectively) was determined for each parasite isolate,
further called FC-PRO. The linear component of
the variability of the expression level of each gene
during in vitro growth was modelled in a multiple
linear regression. Predictors testedwere the examined
time-points during in vitro promastigote growth
and the SbV susceptibility of the studied isolates.
The signiﬁcance of the regression coeﬃcient corres-
ponding to the SbV-susceptibility was used to test
diﬀerence in intercepts (change in baseline or initial
gene expression level) between the SbV-sensitive
(further called SbV-S) and SbV-resistant (further
called SbV-R) isolates. The interaction between
the examined time and the SbV susceptibility was
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Table 2. Genes selected for expression proﬁling of Leishmania braziliensis: primer sequences, qPCR conditions and reproducibility of assays
Gene Product Function/Relevance GeneDB ID Forward/Reverse Primera
Primer ﬁnal
concentration
(nM)
%
CVb
LbAQP1c aquaglyceroporin membrane channel for transport of
water and small solutes; possible role
in volume regulation and osmotaxis
LbrM31_V2.0020 5′ CTTTGCGGTGTGGAGTGAGATA 3′ 600 7·6
5′ CCAGAGTTGATACCTGTCGTGATAC 3′
MRPA ABC-thiol transporter intracellular ABC transporter,
presumably involved in sequestration
metal-thiol conjugates
LbrM23_V2.0280 5′ AAGTGGGCAGCGACTCAAA 3′ 400 4·6
5′ CCAGTTCAGCGTCTCCGTT 3′
ACR2¥ hypothetical protein,
conserved
putative arsenate reductase 2; protein
tyrosine phosphatase activity and
metal reductase activity in presence
of glutathione
LbrM32_V2.2980 5′ CAAACCTGATTCGTTCGCCA 3′ 500 3·3
5′ CAATGAAGCCGCAGTCTCG 3′
TDR1 thiol-dependent
reductase 1
homologue of glutathione S-transferase LbrM31_V2.0550 5′ GCTTCTTCCTGGACAACGC 3′ 500 3·9
5′ CTCAAACTCAGCCTTCGCATC 3′
GSH1c gamma-glutamylcysteine
synthetase, putative
(γ-GCS)
key enzyme in glutathione
biosynthesis (rate limiting step)
LbrM18_V2.1700 5′ CTACGACTCTATCTCCATCTTCATCA 3′ 600 5·7
5′ CACACCAGCCTTCTCCAGC 3′
GSH2 glutathione synthetase,
putative (GS)
second step in glutathione biosynthesis
(downstream of γ-GCS)
LbrM14_V2.0880 5′ ACGAAGAGCGACGACCCA 3′ 400 3·0
5′ GTGACGCCGTAGATGCCA 3′
ODC ornithine decarboxylase,
putative
key enzyme in spermidine biosynthesis LbrM12_V2.0300 5′ CAGTCTGTCGTGCCGATGGA 3′ 500 4·9
5′ CGTTCAGCAGGAGAAGCGTC 3′
TRYR trypanothione reductase central oxidoreductase for maintenance
cellular redox potential
LbrM05_V2.0350 5′ GAAAAGGATGGCGAGGTGC 3′ 500 6·2
5′ AGATGCCTACGCTCTGAATGAT 3′
Actind actin cytoskeletal structural protein LbrM04_V2.1250 5′ GGCGAACGAGGAGTCATTTG 3′ 500 5·1
5′ ATCAGCGACGGCTTGAACAG 3′
S8c,d 40S ribosomal protein S8,
putative
structural constituent of large subunit
ribosome
LbrM24_V2.2160 5′ CGACTTGGATGCGGGGA 3′ 600 6·0
5′ GGCGAAGCCTTGTTCACG 3′
PAP14c,d poly(A) polymerase,
putative
polyadenylation precursor mRNA LbrM14_V2.1350 5′ CCTGCTACAATGTTACCCTCACC 3′ 300 3·4
5′ GAACTTCGCCTCCGCCTC 3′
PABPd RNA-binding protein,
putative
putative poly(A)-binding protein;
co-factor for polyadenylation
LbrM30_V2.2560 5′ CGCCAGGGAAACCCAAAG 3′ 400 3·1
5′ CCGTGTAGAGACTGCCCATCC 3′
META1c hypothetical protein,
conserved
putative infective insect stage-speciﬁc
protein META1
LbrM17_V2.0980 5′ GGGCAGCGATGACTTGAT 3′ 400 7·4
5′ CACCAACTTGCCATCCTC 3′
GeneDB ID, gene Accession number onGeneDB (http://www.genedb.org/); Product, predicted gene function based on orthologues in the diﬀerent TriTrypDB organisms [annotation
from GeneDB and TriTrypDB (http://tritrypdb.org/tritrypdb/) databases].
a Leishmania-speciﬁc primer sets.
b Mean coeﬃcient of variation [CV=(standard deviation/mean)*100] of normalized relative quantities between biological replicates (calculated across all measurements).
c Primers and qPCR conditions as reported previously (Gamboa et al. 2007).
d Primers developed by Decuypere (2007).
¥ Potential orthologous gene and protein sequences in L. major (LmjF32.2740 at GeneDB) are annotated as ACR2 and Sb(V)-As(V) reductase (LmACR2) at GenBank (Accession
numbers: AY567836.1, AAS73185.1, respectively).
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included, and the signiﬁcance of the regression
coeﬃcient corresponding to the interaction term
was used to test diﬀerence in slopes (change in gene
expression level along time) between the SbV-S and
SbV-R isolates. To increase the strength of the
evidence, a signiﬁcance level of 0·01 was considered.
To achieve biological signiﬁcance we only considered
cases where the slope ratio or the intercept ratio
(between the SbV-S and SbV-R groups) was 52, as
recommended elsewhere (McCarthy and Smyth,
2009).
A multiple logistic regression to model the SbV
susceptibility using the ODC and TRYR slopes
(gene expression rate) and intercepts (baseline gene
expression level) as predictors for all the isolates was
performed. A linear score to estimate the probability
of SbV-resistance was developed based on the best
regression model. An isolate was predicted to be
SbV-resistant if the probability was greater than the
best cutoﬀ (Pr-cutoﬀ). A Receiver Operating Charac-
teristic curve (ROC) was calculated and the Pr-
cutoﬀ was estimated in order to maximize the
Youden’s J-index (Sensitivity+Speciﬁcity−1)
(Youden, 1950). The 95% Conﬁdence Intervals
(CI) for the estimated sensitivity and speciﬁcity
were calculated for proportions following a binomial
distribution. All the analysis was performed using the
statistical software Stata 10 (StataCorp).
RESULTS
Gene expression proﬁling throughout the promastigote
growth cycle of L. braziliensis isolates
In order to assess for each gene the extent of
expression regulation during in vitro promastigote
growth/diﬀerentiation ofL. braziliensis, we examined
the fold change in mRNA abundance from log- to
stationary phase (FC-PRO) in all isolates. The
expression level of 8 genes did not change signiﬁ-
cantly during the promastigote growth cycle (FC-
PRO <2), a pattern common to all 21 isolates. Genes
in this category include: ACR2, Actin, GSH2,
MRPA, PABP, PAP14, S8 and TDR1. Five genes
showed a signiﬁcant up-regulation of expression
(FC-PRO 52), each of them in a diﬀerent set of
isolates, hereby providing a ‘mosaic’ picture of gene
expression in the present sample (Fig. 1). Three of
these genes showed signiﬁcant up-regulation in very
few isolates:GSH1 (2 isolates, both SbV-R),META1
(4 isolates – one SbV-S and 3 SbV-R) and ODC
(4 isolates, all SbV-R). The last two genes, LbAQP1
Fig. 1. Gene expression and phenotype mosaic. Schematic representation of the signiﬁcantly modulated gene expression
(highlighted in black if FC-PRO52, see Materials and Methods section) in the 21 isolates here studied. Schematic
representation of the phenotype diversity: (i) in vitro SbV susceptibility (grey if resistant), (ii) in vitro SbIII susceptibility
(grey if resistant; N, not available), (iii) clinical form (grey if ML, otherwise CL) and (iv) treatment outcome (grey if
failure, otherwise cure).
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andTRYR, showed a FC-PRO52 inmore than 50%
of the isolates (19/21 isolates for LbAQP1; 12/21
isolates for TRYR). The isolates showing growth-
dependent changes in LbAQP1 corresponded to the
4 SbV-S isolates and 15/17 SbV-R isolates. As for
TRYR, 3/4 SbV-S isolates and 9/17 SbV-R isolates
showed modulated expression during promastigote
growth. Interestingly, when other phenotypes associ-
ated with the parasites were taken into consideration,
it appeared that 9/10 isolates from patients with
treatment failure showed a signiﬁcant up-regulation
of TRYR expression during growth, vs 3/11 from
cured patients (Fig. 1).
Comparison of gene expression proﬁles during
promastigote growth between L. braziliensis isolates,
in relation to the in vitro SbV susceptibility
Next, we compared the gene expression patterns
between SbV-S and SbV-R L. braziliensis isolates.
We did a multiple linear regression in order to
identify genes showing diﬀerential expression be-
tween these 2 groups of isolates. We did not ﬁnd
signiﬁcant diﬀerences in the baseline expression level
(intercept); only the slopes were informative, hereby
further validating the importance of analysing gene
expression curves. A signiﬁcant diﬀerence was
observed between SbV-S and SbV-R isolates in slopes
for 2 genes, ODC and TRYR (Table 3). The change
in expression level along time (slope) of both genes in
the group of SbV-R isolates was signiﬁcantly higher
than that in the group of SbV-S isolates (P<0·01)
(Table 3, Fig. 2). For the rest of the examined genes,
the slopes of the expression curves were similar
between the 2 groups of SbV-S and SbV-R isolates
(Table 3).
Focusing on ODC and TRYR genes, we also
assessed the slopes of the expression curves of indi-
vidual isolates (Fig. 3A,B) and calculated the sen-
sitivity and speciﬁcity of each marker by comparison
to the in vitro phenotype of SbV-susceptibility.
The best logistic model to predict SbV-resistance
only included the expression rate (slope) of ODC
gene (P=0·06). Based on the Pr-cutoﬀ that maxi-
mized the Youden’s J index, the sensitivity and
speciﬁcity of the ODC expression rate to detect SbV-
resistance was 100% (95% CI: [100%, 100%]) and 50%
(95% CI: [28%, 71%]) respectively. Reciprocally,
speciﬁcity of 100% was associated with a sensitivity
of 24%. The sets of sensitivity/speciﬁcity and their
relationship are shown in Fig. 4a. The assay eﬃcacy,
measured by Youden’s J index, was 0·5, and the
area under the ROC curve was 0·72. With regard to
data of TRYR, the logistic model to predict SbV-
resistance did not achieve statistical signiﬁcance
(P=0·61). Based on the Pr-cutoﬀ that maximized
the Youden’s J index, the sensitivity and speciﬁcity of
the TRYR expression rate to detect SbV-resistance
was 76% (95% CI: [51%, 92%]) and 50% (95% CI:
[44%, 65%]) respectively (Fig. 4c). The assay eﬃcacy,
measured by Youden’s J index, was 0·26, and the area
under the ROC curve was 0·53.
Comparison of gene expression proﬁles during
promastigote growth between L. braziliensis isolates,
in relation to the treatment outcome
Finally, we analysed among individual isolates the
sensitivity and speciﬁcity of ODC and TRYR slope
values in comparison to the antimonial treatment
outcome. With regard to data of ODC and TRYR,
Table 3. Comparison of slope and intercept
parameters of modelled expression levels
of examined genes between SbV-sensitive and
SbV-resistant Leishmania braziliensis isolates
Gene
SbV-S
isolates
(n=4)
Slope/
Intercept§
SbV-R
isolates
(n=17)
Slope/
Intercept§
Slope/
Intercept
diﬀerence
SbV-S vs.
SbV-R isolates
P-value
ACR2 0·0011 −0·0004 0·0410
0·9284 0·9857 0·2400
Actin −0·0014 −0·0033 0·3990
1·0556 1·3199 0·0690
LbAQP1 0·0122 0·0087 0·2910
0·0921 0·2699 0·4230
GSH1 0·0047 0·0050 0·4230
0·6191 0·5966 0·8220
GSH2 0·0004 −0·0004 0·3450
0·9506 1·0091 0·2670
META1 0·0083 0·0010 0·0430
0·4905 0·7126 0·3450
MRPA 0·0015 0·0011 0·7080
0·8588 0·9118 0·4920
ODC 0·0029 0·0092 0·0010
0·6869 0·4715 0·0850
PABP 0·0006 0·0006 0·9960
1·0421 0·9760 0·5400
PAP14 0·0002 0·0011 0·1720
1·0495 0·9214 0·0050
S8 −0·0009 0·0004 0·4050
1·0409 1·0644 0·8180
TDR1 −0·0015 −0·0006 0·4420
1·0946 1·1209 0·7120
TRYR 0·0038 0·0121 0·0000
0·5116 0·3703 0·2410
SbV-S, in vitro sensitive to pentavalent antimony; SbV-R,
in vitro resistant to pentavalent antimony; n, number of
isolates in each group.
§ Shown are the slopes (ﬁrst line in italics) and the inter-
cepts (second line) derived from multiple linear regression
analysis of the variability of the expression level of each
gene during promastigote growth/diﬀerentiation. Genes
for which (i) statistically signiﬁcant comparisons (P<0·01)
between the groups of SbV-S and SbV-R isolates and
(ii) ratio between slopes or intercepts was52 (seeMaterials
and Methods section) are highlighted in bold text.
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the logistic model to predict treatment outcome did
not achieve statistical signiﬁcance (P=0·291 for
ODC, and P=0·229 for TRYR). Based on the Pr-
cutoﬀ that maximized the Youden’s J index, the
sensitivity and speciﬁcity of the ODC expression rate
to detect antimonial treatment failure was 100% (95%
CI: [100%, 100%]) and 36% (95% CI: [15%, 57%])
respectively (Fig. 4b). The assay eﬃcacy, measured
by Youden’s J index, was 0·36, and the area under
the ROC curve was 0·6364. With regard to data of
TRYR, the sensitivity and speciﬁcity of the TRYR
expression rate to detect antimonial treatment fail-
ure was 50% (95% CI: [28%, 71%]) and 90% (95%
CI: [77%, 100%]) respectively (Fig. 4d). The assay
eﬃcacy,measured byYouden’s J index, was 0·41, and
the area under the ROC curve was 0·70.
DISCUSSION
The present paper is, to our knowledge, the ﬁrst to
report results of the molecular characterization of
clinical isolates of L. braziliensis in the context of
in vitro SbV susceptibility. Our targeted approach
focused on the analysis of expression proﬁles of
genes putatively involved in SbV metabolism and/
or implicated in laboratory-induced resistance
(Ashutosh et al. 2007) in the present collection of
L. braziliensis isolates, naturally SbV-resistant or
Fig. 2. Diﬀerential expression rate of genes ODC and TRYR between SbV-sensitive (n=4) and SbV-resistant (n=17)
Leishmania braziliensis isolates. The relative expression levels of each gene [re-scaled relative to the sample with the
lowest expression] and the estimated linear regression lines are shown for each group of isolates. The 2 independent
biological replicates analysed at each time-point for a given isolate are labelled with the same symbol. Time-points
during in vitro promastigote growth/diﬀerentiation: 24 h, parasites harvested at early-log phase; 72 h, parasites harvested
at late-log phase; 120 h, parasites harvested at early-stationary phase; 168 h, parasites harvested at late-stationary phase.
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-sensitive. It allowed assessment of the extent and
types of variability in gene expression patterns that
occur under a natural context.
Herein, we ﬁrst analysed the gene expression
patterns throughout the promastigote growth cycle
of L. braziliensis isolates, independently of their
in vitro SbV susceptibility. This revealed for 8 genes
a striking picture of non-modulated transcript pat-
terns during the growth cycle. In the 5 remaining
genes (GSH1, META1 and ODC, LbAQP1 and
TRYR), there was a ‘mosaic’ of up-regulated ex-
pression among the studied isolates. In the context
of stage-related gene expression, the META1 gene
deserves speciﬁc attention. Indeed, it has already
been shown to be up-regulated in the infective
metacyclic stage of distinct Leishmania species
(Uliana et al. 1999; Gamboa et al. 2007), but in the
present study, less than 25% of isolates exhibited a
signiﬁcantly higher expression in late-stationary
phase (FC-PRO 52). Even if all our isolates were
infective (as demonstrated by the in vitro suscepti-
bility assays undertaken in macrophages, Yardley
et al. 2006; Rijal et al. 2007), further work is needed
to determine (i) if this low proportion of META1
expression up-regulation reﬂects variations in the
level of metacyclogenesis among our isolates as
reported elsewhere (Da Silva and Sacks, 1987) or
(ii) if the validity of META1 as a metacyclogenesis
marker should be questioned.
In a second stage, we analysed the gene expression
patterns in the context of the in vitro SbV resistance as
deﬁned by the reference biological assays. Two genes,
ODC and TRYR, showed a signiﬁcantly diﬀerent
change in expression level (slope of the expression
curve) between the 2 groups of in vitro SbV-S and
SbV-R isolates. However, analysis of individual
slopes revealed an overlap in the distribution of
slopes, with a direct impact on the sensitivity and
speciﬁcity of the respective markers. High sensitivity
was generally accompanied by low speciﬁcity and
vice-versa. Taking an arbitrary cut-oﬀ with the
highest speciﬁcity, ODC slopes provided the best
performances among the genes studied, but this
corresponded to a sensitivity of 24% only. In other
words, when using this marker under stringent con-
ditions, it could only identify a fourth of the in vitro
SbV resistant isolates of the present sample.
The low sensitivities of ODC and TRYR markers
by comparison to the in vitro-deﬁned SbV suscepti-
bility could be explained in diﬀerent ways. First,
diﬀerent mechanisms of resistance might have been
selected by diﬀerent L. braziliensis subpopulations.
Thus, in a subpopulation of L. braziliensis isolates,
alteration of ODC gene expression might be linked
with resistance, a phenomenon reported in metal-
resistant laboratory mutants (Haimeur et al. 1999).
In another L. braziliensis subpopulation, other gene
(s) would be involved, like TRYR, also reported in
L. donovani to be related with resistance (Mandal
et al. 2007; Mittal et al. 2007). In other subpopu-
lations, other genes not detected yet could be in-
volved. The hypothesis of a pleiotropic response of
the parasite to drug pressure is supported by previous
observations in L. donovani (Decuypere, 2007;
Laurent et al. 2007). Analysis of additional genes
possibly involved in antimony resistance might
provide a clue to this question, but with the avenue
of new high-throughput sequencing technologies,
it would be more powerful in a next exploration stage
to address the whole genome or transcriptome than
to pursue with targeted, and hereby possibly biased,
studies (Dujardin, 2009). Later, the most robust (set
of) markers could be assembled in a simple monitor-
ing tool.
Secondly, it is possible that molecular adaptations
in L. braziliensis promastigote stages could be diﬀer-
ent than in L. donovani, impeding the discrimination
of SbV-resistant and -sensitive isolates by gene
expression studies. Our previous study on Nepalese
L. donovani clinical isolates indicated that pro-
mastigote expression-curves could reveal molecular
features distinguishing isolates with diﬀerent
in vitro SbV susceptibility phenotypes (Decuypere
et al. 2008). The comparative genomic analysis of
L. major, L. infantum and L. braziliensis (Peacock
Fig. 3. Distribution of slopes corresponding to the gene
expression proﬁle of individual isolates resistant or
sensitive to SbV, for ODC (A) and TRYR (B).
The horizontal line denotes the mean of slope values
in each group of isolates.
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et al. 2007; Smith et al. 2007) showed the presence
of a putative RNAi machinery in the latter species,
which might have an eﬀect on gene expression
regulation. In line with this, the comparison of the
organization of the H locus conserved repeats
betweenL. braziliensis andL. major resistantmutants
did not show ampliﬁed episomal molecules in
L. braziliensis (Dias et al. 2007). Furthermore, we
cannot exclude that point mutations in important
functional sites could be also related to resistance in
L. braziliensis.
Thirdly, the antimony susceptibility phenotype
deﬁnition, as currently established by the in vitro
macrophage-amastigote assays, should also be con-
sidered. Indeed, diﬀerent epi-phenotypes to which
the parasites could have developed speciﬁc adap-
tations might remain hidden in the in vitro SbV
susceptibility assays, but interfering with the gene
expression patterns. For instance, (i) the variable
adaptation to the macrophage eﬀectors in the im-
munological context of the clinical infection
(absent in the in vitro susceptibility assays) or
(ii) the resistance to the reduced form of the drug,
SbIII (Yardley et al. 2006; Rijal et al. 2007). These
epi-phenotypes would explain the incongruences
between the parasites’ in vitro SbV resistance and
chemotherapy failure reported elsewhere (Yardley
et al. 2006; Rijal et al. 2007) and illustrated in
Table 1. More speciﬁcally, half of the parasites
isolated before treatment from patients who later
showed a deﬁnitive cure were found in vitro to be
resistant to SbV. Interestingly, the P-value of the
logistic model for TRYR results was much lower in
the context of treatment outcome (0·229) than in the
context of in vitroSbV resistance (0·61). This is in line
with the observations made when classifying the
isolates according to the signiﬁcant up-regulation
(FC-PRO52) of TRYR expression during growth:
(i) 9/10 and 3/11 in isolates from patients with
treatment failure and success respectively and (ii)
9/17 and 3/4 in isolates respectively SbV-resistant and
sensitive. In a parallel study of Brazilian isolates,
using the same protocol as here described, we did
not ﬁnd any informative diﬀerence in L. braziliensis
isolates from SbV treatment failure, but sample size
was much smaller than in the present study (Torres
et al. 2010). However, analysis of 25 L. guyanensis
isolates revealed an overexpression of GSH1 in
promastigotes of strains from treatment failure,
hereby further validating our methodology (Torres
et al. 2010). In the present study, GSH1 was not as
discriminative in L. braziliensis and this could reﬂect
diﬀerences between species or geographical popu-
lations (Arevalo et al. 2007).
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Fig. 4. Sensitivity/Speciﬁcity curves calculated from the multiple logistic regression model using the ODC or TRYR
slopes as predictors of in vitro SbV susceptibility (a, c) or antimonial treatment outcome (b, d) for all the isolates.
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Further work with larger cohorts would be needed
to verify these trends. Special attention could also
be paid to the analysis of parasites isolated after
treatment failure (in the present study, most of them
were isolated before treatment), as drug pressure
could also aﬀect or select the expression pattern of
several genes.
Variation in the gene expression of ODC and
TRYRmight thus contribute to explain only a small
part of the variation in phenotype of in vitro SbV
susceptibility in the present sample of L. braziliensis
isolates. Further work is needed to identify a marker
or a set of markers of SbV resistance as well as the best
parasite stage in which to apply it. This molecular
exploration should take into account a phenotype
deﬁnition that may be more complex than that
revealed by the in vitro SbV biological assays.
Certainly, a second step in our exploration should
consider the amastigote stages. Indeed, this latter
model already implied overexpressed genes in SbV-
resistant L. donovani isolates (Decuypere et al. 2005;
Mukherjee et al. 2007). However, this life stage is
extremely sensitive to minimal disturbance of the
parasite’s environment during harvesting, hence
extreme care is needed to ‘freeze’ gene expression
levels instantly (Decuypere et al. 2008). In that sense,
axenic amastigotes might represent an interesting
biological compromise between promastigotes and
intracellular amastigotes, but axenization is not
straightforward for some species and for clinical
isolates.
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